Latent Viral Infection of Lymphoid Cells in Idiopathic Nephrotic Syndrome
NCT00577525 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 401
Last updated 2014-02-27
Summary
The primary purpose of the study is to evaluate the association of a latent infection of lymphoid cells during the first manifestation of steroid sensitive nephrite syndrome. The thirty nine units of general pediatrics and pediatric nephrite covering the parisian area will participate to the study. We speculate that hybridization of the genome, or a part of the genome, of a virus in lymphoid cells is responsible specific changes of genes expression, leading to the development of the disease.
Conditions
- NEPHROSIS, LIPOID
Sponsors & Collaborators
-
Assistance Publique - Hôpitaux de Paris
lead OTHER
Principal Investigators
-
Georges DESCHENES, PHD · Assistance Publique - Hôpitaux de Paris
Eligibility
- Min Age
- 1 Year
- Max Age
- 16 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2007-12-31
- Primary Completion
- 2010-07-31
- Completion
- 2012-02-29
Countries
- France
Study Locations
More Related Trials
-
Rituximab in the First Episode of Paediatric Nephrotic Syndrome
NCT05850546 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Mycophenolate Mofetil in Pediatric Steroid Dependent Nephrotic Syndrome
NCT01895894 ·Status: COMPLETED ·Phase: PHASE4
-
Cyclophosphamide Versus Mycophenolate Mofetil for the Treatment of Steroid-dependent Nephrotic Syndrome in Children
NCT01092962 ·Status: COMPLETED ·Phase: PHASE3
-
Cyclosporine Adverse Outcomes in Steroid Dependent and Frequent Relapsing Nephrotic Syndrome in Children;Single Center Study
NCT05588869 ·Status: UNKNOWN
-
Studies of the Natural History, Pathogenesis, and Outcome of Autoinflammatory Diseases Including Juvenile Dermatomyositis
NCT00059748 ·Status: RECRUITING
-
Dupilumab Therapy in Nephrotic Syndrome in Children
NCT07091175 ·Status: RECRUITING ·Phase: PHASE2
-
Evaluation of Low Dose Corticosteroids Efficiency, Associated With Myfortic ® in the Treatment of Nephrotic Syndrome
NCT01197040 ·Status: COMPLETED ·Phase: PHASE3
-
Registry of IgA Nephropathy in Chinese Children
NCT03015974 ·Status: RECRUITING
-
Rituximab for Idiopathic Nephrotic Syndrome
NCT04494438 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Efficacy and Safety of Iptacopan in Participants With IC-MPGN
NCT05755386 ·Status: RECRUITING ·Phase: PHASE3
-
The Research of Standard Diagnosis and Treatment for HSPN in Children
NCT02532777 ·Status: UNKNOWN ·Phase: PHASE2
-
Role of Anti-mouse PLA2R1 ELISA in Membranous Nephropathy
NCT02199145 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety of Losartan in Children With Ig A Nephropathy
NCT02232776 ·Status: COMPLETED ·Phase: PHASE3
-
Lymphocyte Markers As Predictors Of Responsiveness To Rituximab Among Patients With Idiopathic Nephrotic Syndrome
NCT03501459 ·Status: RECRUITING ·Phase: PHASE3
-
Role of the Nuclear Pore Component RANBP2 in Inflammatory Responses to Viral Infections
NCT06731790 ·Status: COMPLETED ·Phase: NA
-
Study of Autoimmune Lymphoproliferative Syndrome (ALPS)
NCT00001350 ·Status: RECRUITING
-
B Cells in Idiopathic Nephrotic Syndrome
NCT05712369 ·Status: COMPLETED ·Phase: NA
-
Establishment of an Early Warning Screening System for Hemophagocytic Lymphohistiocytosis a Multi-center, Prospective Study
NCT06614998 ·Status: RECRUITING
-
The Research of Standard Diagnosis and Treatment for HSPN With Mild Proteinuria in Children
NCT02532790 ·Status: UNKNOWN ·Phase: PHASE2
-
Validation of the IgA1 Detection Method With Gradient Glycosylation by Mass Spectrometry as a Potential Marker of Renal Involvement in Pediatric Rheumatoid Purpura
NCT04655378 ·Status: COMPLETED
-
A Study of Anti-CD38 Monoclonal Antibody (SG301) Subcutaneous Injection in Children With Nephrotic Syndrome With Frequent Relapses or Steroid Dependence
NCT07087314 ·Status: RECRUITING ·Phase: PHASE2
-
Immun Response in Children With MIS-C
NCT05052424 ·Status: UNKNOWN
-
Analysis of T- and B-Cell Subpopulations in Membranous Nephropathy
NCT05894512 ·Status: COMPLETED
-
Pilot Study to Evaluate the Safety and Efficacy of Abatacept in Adults and Children 6 Years and Older With Excessive Loss of Protein in the Urine Due to Either Focal Segmental Glomerulosclerosis (FSGS) or Minimal Change Disease (MCD)
NCT02592798 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Rituximab Versus Mycophenolate Mofetil in Children With Steroid-dependent Nephrotic Syndrome
NCT05843968 ·Status: RECRUITING ·Phase: PHASE2